Covered recipient · General Payments record
JAYANTI VENKATESAN
Allopathic & Osteopathic Physicians Internal Medicine Nephrology
General Payments · PY2018–2024
$2,519.20
- Reported across 129 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $241.43 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $56.10 | 1 |
| Amgen Inc. | $45.74 | 2 |
| Corcept Therapeutics | $41.66 | 2 |
| Mallinckrodt Hospital Products Inc. | $35.32 | 1 |
| Lilly USA, LLC | $19.39 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $16.05 | 1 |
| Retrophin, Inc. | $15.57 | 1 |
| BETA BIONICS, INC. | $11.60 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $19.43 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111733053 | CMS |
| Amgen Inc. | $26.31 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111733055 | CMS |
| AstraZeneca Pharmaceuticals LP | $56.10 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104546236 | CMS |
| BETA BIONICS, INC. | $11.60 | 12/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087890315 | CMS |
| Corcept Therapeutics | $21.48 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117743894 | CMS |
| Corcept Therapeutics | $20.18 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117743910 | CMS |
| Lilly USA, LLC | $19.39 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135055076 | CMS |
| Mallinckrodt Hospital Products Inc. | $35.32 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145149463 | CMS |
| RECORDATI_RARE_DISEASES_INC. | $16.05 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139167185 | CMS |
| Travere Therapeutics, Inc. | $15.57 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149875652 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.